KOSPI · Healthcare · ₩217B
₩6,850+2.24%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
8/'26
5/'26 vs prev quarter
Short Volume 1.5% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“이번 분기 의약품과 음료 양쪽이 함께 살아나며 이익이 크게 회복됐어요.”
In the company's words · 2026 2분기 filing